Director/PDMR Shareholding

RNS Number : 3111P

MyCelx Technologies Corporation

05 June 2015

 



5 June 2015

MyCelx Technologies Corporation

("MyCelx" or the "Company" (AIM: MYX))

Dealing by Directors

The Company announces that on 3 June 2015, Tim Eggar, Chairman and a Director of the Company, notified the Company that he had exercised options over 50,459 common shares of US$0.025 each ("Common Shares") under the Company's Omnibus Performance Incentive Plan 2011 (the "Plan") at a price of US$0.86 per Common Share.

Following this transaction, Mr Eggar now holds 130,679 Common Shares, representing 0.70 per cent of the increased issued capital of the Company.

The Company further announces that on 3 June 2015, Brian Rochester, a Director of the Company, notified the Company that he had exercised options over 41,143 Common Shares under the Plan at a price of US$0.86 per Common Share.

Following this transaction, Mr Rochester now holds 41,143 Common Shares, representing 0.22 per cent of the increased issued capital of the Company.  R. Bros. Investments LLC, in which Mr Rochester holds a 50% interest, also holds 191,305 Common Shares representing 1.02 per cent of the increased issued capital of the Company.  Mrs Alana Rochester, Mr Rochester's wife, also holds 32,044 Common Shares, representing 0.17 per cent of the increased issued capital of the Company.  

Exercise of Share Option by Significant Shareholder

The Company further announces that on 3 June 2015, John Mansfield Sr., Chairman Emeritus and co-founder of the Company and a former Director of the Company, notified the Company that he had exercised an option over 54,340 Common Shares under the Plan at a price of US$0.86 per Common Share.  In accordance with the provisions of the Plan, the subscription price for 32,296 Common Shares forming part of this option was settled by the cancellation of the balance of 22,044 Common Shares, based on the market value of the Common Shares at the time of exercise.

Following this transaction, Mr Mansfield now holds 1,703,380 Common shares, representing 9.07 per cent of the increased issued capital of the Company. This aggregate number of shares includes a holding by Mansfield Holdings LLC, a limited liability company controlled by Mr Mansfield, of 205,082 Common Shares representing 1.09 per cent of the increased issued capital of the Company.  

Exercise of Share Option

The Company further announces that on 3 June 2015, an option over 24,065 Common Shares under the Plan was exercised by a former director at a price of US$0.86 per Common Share.  In accordance with the provisions of the Plan, the subscription price for 14,439 Common Shares forming part of this option was settled by the cancellation of the balance of 9,626 Common Shares, based on the market value of the Common Shares at the time of exercise, and 14,439 Common Shares have been allotted.

Block Admission

A total of 138,337 new Common Shares have been allotted under the Company's Block Admission of 300,000 Common Shares admitted to AIM on 29 April 2013.

Total Voting Rights

Following the issue of 138,337 new Common Shares referred to above, the total number of voting rights in the Company's Common Shares is 18,770,117 which may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, MyCelx under the Financial Conduct Authority's Disclosure and Transparency Rules. The Company does not hold any Common Shares in treasury.

For further information please contact:

MyCelx Technologies Corporation

Connie Mixon, CEO

Mark Clark, CFO

Tel: [phone]

Numis Securities Limited

Corporate Finance 

John Prior

Paul Gillam

Corporate Broking

James Black

Ben Stoop

Tel: [phone]

Bell Pottinger

Nick Lambert

Henry Lerwill

Tel: [phone]

 

END

 

 

RDSLFFFIRLISIIE